Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

Tesaglitazar

Name Tesaglitazar
Supplier R&D Systems
Catalog 3965
Prices $199.00, $825.00
Sizes 10 mg, 50 mg
Cas Number 251565-85-2
Chemical Name (S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoicacid
Formula C20H24O7S
Molecular Weight 408.47
Purity >98%
Supplier Page Shop

Product References

Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ - Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ

Cronet P, Petersen JF, Folmer R, Blomberg N, Sjoblom K, Karlsson U, Lindstedt EL, Bamberg K. Structure. 2001 Aug;9(8):699-706.

AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin - AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin

Ljung B, Bamberg K, Dahllof B, Kjellstedt A, Oakes ND, Ostling J, Svensson L, Camejo G. J Lipid Res. 2002 Nov;43(11):1855-63.

Synthesis and biological and structural characterization of the dual-acting - Synthesis and biological and structural characterization of the dual-acting

Ebdrup S, Pettersson I, Rasmussen HB, Deussen HJ, Frost Jensen A, Mortensen SB, Fleckner J, Pridal L, Nygaard L, Sauerberg P. J Med Chem. 2003 Apr 10;46(8):1306-17.

The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing - The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing

van der Hoorn JW, Jukema JW, Havekes LM, Lundholm E, Camejo G, Rensen PC, Princen HM. Br J Pharmacol. 2009 Apr;156(7):1067-75.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved